此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effectiveness of Physical Activity Prescription Among Hypertensive Patients of Primary Health Care.

The purpose of this study is to evaluate the effectiveness of a program to increase the physical activity of hypertensive patients using medical services and sports facilities of the Mexican Social Security Institute. The primary hypothesis to be proven is: The intervention will increase the proportion of hypertensive patients complying the physical activity minimum at week to get benefits on health in 20%, compare to patients in control group.

研究概览

详细说明

Secondary Hypothesis:

The intervention achieved a significant change in the group of hypertensive patients in the following variables:

  1. Decreased levels of systolic and diastolic blood pressure, biochemical markers such as total cholesterol, triglycerides and fasting blood glucose and increased HDL cholesterol.
  2. Increase muscular endurance and cardio-respiratory capacity according to the categories of risk stratification.
  3. Decreased body weight, body mass index and waist circumference.

研究类型

介入性

注册 (实际的)

224

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Morelos
      • Cuernavaca、Morelos、墨西哥、62000
        • Instituto Mexicano del Seguro Social. Morelos. HGR/MF. No, UMF 3, UMF 20, UMF 23

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

35年 至 70年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • diagnosed with high blood pressure <5 years of evolution and / or without use of drug therapy to treat that condition;
  • with low levels of physical activity (PA) or physically inactive (less than 150 minutes of PA at week, intensity moderate to vigorous);
  • with availability to PA practice or considering begin to PA practice within the next six months (contemplation or preparation stages of the Transtheoretical Model).
  • Without cardiovascular risk (assessed previously);
  • Without physical or mobility problems that impede PA practice;
  • Willingness to participate in the study, fulfill with outlined activities to develop the proposal.

Exclusion Criteria:

  • high-risk patients according to the risk stratification of the American College of Sports Medicine;
  • fulfill the high recommendation of physical activity (more than 300 minutes per week of moderate to vigorous intensity);

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Physical activity prescription
24 weeks physical activity program. 1 hour, 3 times a week, moderate to vigorous intensity.
Overall the intervention involves a medical reference in primary care (PHC) to hypertensive patients (during routine consultation) to assist the sports facilities of the same Institute, to develop a group program of physical activity which will last 24 weeks. Led by the trained staff in physical activity to patients with chronic diseases.
无干预:No physical activity prescription
Provide information to patients about the benefits of physical activity and how to increase it safely.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Physical activity. Level of physical activity between intervention and control groups.
大体时间:24 weeks

The length of the intervention is 24 weeks, the control group will be followed for 24 weeks also. The outcome measure is a composite at three moments of the study. Basal measurement, 24 weeks and 36 weeks, this last moment to assess sustainability of the intervention.

The intervention will be effective if the difference in the percent of population (complying the minimum recommended of physical activity) among control and intervention groups is at least of 20%.

24 weeks

次要结果测量

结果测量
措施说明
大体时间
Blood pressure
大体时间:24 weeks
Blood pressure among intervention and control groups, at the three moments of the study: basal measurement, 24 weeks (end of the intervention) and 36 weeks. The outcome measure is a composite at three moments of the study. Basal measurement, 24 weeks and 36 weeks, this last moment to assess sustainability of the intervention.
24 weeks

其他结果措施

结果测量
措施说明
大体时间
Composite measure of biochemical markers: total cholesterol, triglycerides and fasting blood glucose
大体时间:24 weeks
Biochemical markers (total cholesterol, triglycerides and fasting blood glucose) among intervention and control groups, at the three moments of the study: basal measurement, 24 weeks (end of the intervention) and 36 weeks. The secondary outcome measure is a composite at three moments of the study. Basal measurement, 24 weeks and 36 weeks, this last moment to assess sustainability of the intervention.
24 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Gallegos-Carrillo Katia, D. Sc、Instituto Mexicano del Seguro Social/Unidad de Investigación Epidemiologica y en Servicios de Salud.

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2013年7月1日

初级完成 (实际的)

2014年2月1日

研究完成 (实际的)

2014年4月1日

研究注册日期

首次提交

2013年7月5日

首先提交符合 QC 标准的

2013年7月26日

首次发布 (估计)

2013年7月30日

研究记录更新

最后更新发布 (估计)

2014年6月6日

上次提交的符合 QC 标准的更新

2014年6月4日

最后验证

2014年2月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • 2009-785-038
  • FIS/IMSS/PROT/G10/841 (其他标识符:FIS/IMSS)

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅